Arthur M. Krieg, Chief Scientific Officer at Checkmate Pharmaceuticals, Inc. (CMPI), bought 443 shares at $14.16 ($6K) on 2020-12-29, disclosed to the SEC on 2020-12-31.
Open-market purchase of $6k CMPI by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| CMPI | BUY | 2021-05-19 | $349K | — | Filing → |
| CMPI | BUY | 2021-03-31 | $741K | — | Filing → |
| CMPI | BUY | 2021-03-29 | $290K | — | Filing → |